Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label Study of the Efficacy and Safety of SYNB1618 and SYNB1934 in Patients With Phenylketonuria (SynPheny-1)

NCT04534842 is registered in ClinicalTrials.gov with Synlogic as lead sponsor.

NCT NCT04534842
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04534842 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label Study of the Efficacy and Safety of SYNB1618 and SYNB1934 in Patients With Phenylketonuria (SynPheny-1)
Lead sponsor
Synlogic
Phase
Phase 2
Overall status
Completed
Start date
August 25, 2020
Completion date
October 7, 2022
Enrollment
20 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

phenylketonuria